Furthermore, the importance of PAK4 deletion is also supported by the PAK4 inhibitor as well as the late in vivo RNA-seq data, where anti-PD-1 treatment only changed the transcriptome of melanoma PAK4 KO tumors. Here, PAK4 is linked to melanoma.